Breaking News Instant updates and real-time market news.

BA

Boeing

$348.24

10.79 (3.20%)

10:43
10/23/19
10/23
10:43
10/23/19
10:43

Boeing CEO says may consider further 737 rate reductions, line shutdown

Says should the estimate of the anticipated return to service change, Boeing might need to consider possible further rate reductions or other options including a temporary shutdown of the MAX production line.

  • 23

    Oct

BA Boeing
$348.24

10.79 (3.20%)

10/21/19
STFL
10/21/19
DOWNGRADE
Target $60
STFL
Hold
Stifel downgrades Southwest on risk of deal to lessen Boeing dependency
Stifel analyst Joseph DeNardi downgraded Southwest Airlines (LUV) to Hold from Buy with a price target of $60, down from $75. The stock in morning trading is up 7c to $53.55. Southwest is an all Boeing (BA) 737 airline, which makes its business model dependent on 737s, DeNardi tells investors in a research note. Southwest's decision to remove the 737 MAX from its schedule through early February, a "deteriorating" relationship between the Federal Aviation Administration and Boeing, and reports that Boeing may be looking at a 737 MAX rate cut indicate that Southwest "may be nearing a tipping point" where the duration of the MAX grounding pushes it to consider more significant and strategic solutions, including acquisitions, DeNardi contends. The analyst believes an acquisition by Southwest motivated by a desire to diversify away from the MAX "creates significant risks" in the near term for the company. DeNardi today also upgraded shares of JetBlue Airways (JBLU) to Buy from Hold.
10/21/19
STFL
10/21/19
UPGRADE
Target $24
STFL
Buy
JetBlue could be worth $28 in a takeout scenario, says Stifel
Stifel analyst Joseph DeNardi upgraded JetBlue to Buy from Hold with a price target of $24, up from $22. In a research note to investors, DeNardi says that a prolonged grounding of Boeing's (BA) 737 MAX is an "existential threat" to Southwest's (LUV) business model and that the "only reasonable option" Southwest has to address this risk is through an acquisition of JetBlue or Alaska Air (ALK). When combined with JetBlue's attractive CASMx story into 2020, the analyst now sees the increased likelihood of M&A as presenting a sufficiently attractive risk/reward setup to justify an upgrade. JetBlue could be worth $28 in a takeout scenario, DeNardi says. The Stifel analyst downgraded Southwest to Hold from Buy.
10/21/19
10/21/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Boeing (BA) downgraded to Neutral from Outperform at Credit Suisse and to Neutral from Buy at UBS. 2. Spirit AeroSystems (SPR) downgraded to Neutral from Buy at UBS with analyst Myles Walton citing Spirit's "outsized exposure" to Boeing's (BA) 737 Max program for the downgrade. 3. Gildan Activewear (GIL) downgraded to Hold from Buy at Edward Jones. 4. IBM (IBM) downgraded to Neutral from Buy at UBS with analyst Munjal Shah saying he believes it will be difficult for the company to achieve sustainable mid-single digit revenue growth. 5. Alcoa (AA) downgraded to Hold from Buy at Gabelli with analyst Justin Bergner saying Acloa's 12% two day post-earnings rally reflected better than expected proceeds from non-core asset sales and a view that estimates have bottomed. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/22/19
BUCK
10/22/19
NO CHANGE
Target $395
BUCK
Neutral
Buckingham no longer tactically bullish on Boeing amid continued negative news
Buckingham analyst Richard Safran continues to believe issues with Boeing's 737 MAX will be resolved and he sees a year end return to service for the aircraft. However, in light of continued negative news flow and increasingly negative investor sentiment, he has changed his view on the stock and is no longer tactically bullish. He keeps a Neutral rating and $395 price target on Boeing shares.

TODAY'S FREE FLY STORIES

NVST

Envista

$28.37

0.19 (0.67%)

14:45
12/12/19
12/12
14:45
12/12/19
14:45
Options
Envista Holdings call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRX

Brixmor

$21.07

-0.36 (-1.68%)

14:44
12/12/19
12/12
14:44
12/12/19
14:44
Conference/Events
Brixmor management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 11

    Feb

PD

PagerDuty

$22.13

-0.235 (-1.05%)

14:40
12/12/19
12/12
14:40
12/12/19
14:40
Conference/Events
PagerDuty management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 16

    Dec

SPY

SPDR S&P 500 ETF Trust

$315.97

1.56 (0.50%)

, SPX

S&P 500

$0.00

(0.00%)

14:39
12/12/19
12/12
14:39
12/12/19
14:39
Periodicals
U.S. negotiators reach China trade deal, pending Trump approval, Bloomberg says »

U.S. negotiators have…

SPY

SPDR S&P 500 ETF Trust

$315.97

1.56 (0.50%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,752.74

3.63 (0.21%)

14:34
12/12/19
12/12
14:34
12/12/19
14:34
Periodicals
Amazon to open distribution center in Pernambuco, Brazil in 2020, Reuters says »

Amazon said it plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$316.10

1.69 (0.54%)

, SPX

S&P 500

$0.00

(0.00%)

14:34
12/12/19
12/12
14:34
12/12/19
14:34
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

U.S. has deal 'in…

SPY

SPDR S&P 500 ETF Trust

$316.10

1.69 (0.54%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMNFF

MedMen

$0.00

(0.00%)

14:25
12/12/19
12/12
14:25
12/12/19
14:25
Conference/Events
MedMen management to meet with Cantor Fitzgerald »

Analyst Pablo Zuanic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

FB

Facebook

$200.86

-1.37 (-0.68%)

14:22
12/12/19
12/12
14:22
12/12/19
14:22
Periodicals
FTC considers injunction to block Facebook policies on app integration, WSJ says »

The Federal Trade…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRX

Amneal Pharmaceuticals

$5.00

1.515 (43.47%)

14:17
12/12/19
12/12
14:17
12/12/19
14:17
Downgrade
Amneal Pharmaceuticals rating change  »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LUV

Southwest

$54.65

0.67 (1.24%)

, BA

Boeing

$346.36

-3.64 (-1.04%)

14:17
12/12/19
12/12
14:17
12/12/19
14:17
Periodicals
Southwest weighs another delay in 737 MAX's return to schedule, Bloomberg says »

Southwest Airlines (LUV)…

LUV

Southwest

$54.65

0.67 (1.24%)

BA

Boeing

$346.36

-3.64 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 23

    Jan

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
12/12/19
12/12
14:17
12/12/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$200.80

-1.43 (-0.71%)

14:16
12/12/19
12/12
14:16
12/12/19
14:16
Periodicals
FTC considering injunction against Facebook, WSJ says »

The potential FTC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
12/12/19
12/12
14:16
12/12/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITCI

Intra-Cellular

$12.67

0.53 (4.37%)

14:15
12/12/19
12/12
14:15
12/12/19
14:15
Options
Intra Cellular Therapies put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Dec

TISI

Team

$15.98

-0.03 (-0.19%)

14:14
12/12/19
12/12
14:14
12/12/19
14:14
Initiation
Team initiated  »

Team initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTI

British American Tobacco

$39.37

-0.12 (-0.30%)

, MO

Altria Group

$50.38

0.075 (0.15%)

14:11
12/12/19
12/12
14:11
12/12/19
14:11
Periodicals
CDC says many brands likely responsible for vaping-related injuries, Verge says »

The Centers for Disease…

BTI

British American Tobacco

$39.37

-0.12 (-0.30%)

MO

Altria Group

$50.38

0.075 (0.15%)

PM

Philip Morris

$84.20

-0.8 (-0.94%)

IMBBY

Imperial Brands

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

NXGN

NextGen Healthcare

$17.10

-1.01 (-5.58%)

14:11
12/12/19
12/12
14:11
12/12/19
14:11
Hot Stocks
NextGen Healthcare down 6% after guiding 'relatively flat' earnings until FY23 »

In presentation slides…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

AMRX

Amneal Pharmaceuticals

$5.04

1.555 (44.62%)

14:09
12/12/19
12/12
14:09
12/12/19
14:09
Downgrade
Amneal Pharmaceuticals rating change  »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NXGN

NextGen Healthcare

$17.39

-0.72 (-3.98%)

14:08
12/12/19
12/12
14:08
12/12/19
14:08
Earnings
NextGen Healthcare lowers FY20 EPS outlook, raises low-end of FY20 revenue view »

In presentation slides…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

APO

Apollo Global

$44.31

-0.66 (-1.47%)

, GE

General Electric

$11.36

0.375 (3.42%)

14:06
12/12/19
12/12
14:06
12/12/19
14:06
Hot Stocks
Apollo, Athene close the acquisition of GE Capital's PK AirFinance debt business »

Apollo Global Management…

APO

Apollo Global

$44.31

-0.66 (-1.47%)

GE

General Electric

$11.36

0.375 (3.42%)

ATH

Athene Holding

$45.09

1.12 (2.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 26

    Feb

CIEN

Ciena

$41.74

6.29 (17.74%)

14:06
12/12/19
12/12
14:06
12/12/19
14:06
Recommendations
Ciena analyst commentary  »

Ciena's long-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

BMRN

BioMarin

$80.03

1.25 (1.59%)

14:05
12/12/19
12/12
14:05
12/12/19
14:05
Options
BioMarin call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXMD

TherapeuticsMD

$2.39

0.01 (0.42%)

, AMRX

Amneal Pharmaceuticals

$5.15

1.66 (47.63%)

13:59
12/12/19
12/12
13:59
12/12/19
13:59
Recommendations
TherapeuticsMD, Amneal Pharmaceuticals, Merck analyst commentary  »

Stifel says…

TXMD

TherapeuticsMD

$2.39

0.01 (0.42%)

AMRX

Amneal Pharmaceuticals

$5.15

1.66 (47.63%)

MRK

Merck

$89.27

0.31 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

HURN

Huron

$69.15

0.23 (0.33%)

13:57
12/12/19
12/12
13:57
12/12/19
13:57
Conference/Events
Huron management to meet with Benchmark »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

13:55
12/12/19
12/12
13:55
12/12/19
13:55
Conference/Events
The FDIC to hold a Board Meeting »

Board of Directors…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.